Comment from GenBioPro, Inc.

Summary: GenBioPro, Inc., a generic manufacturer of mifepristone, supports the current safety and efficacy profile of the medication and opposes the imposition of additional restrictions. The company argues that the FDA's review should be based on robust, peer-reviewed scientific evidence rather than flawed, non-transparent third-party reports.